🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06835179
Treatments Being Tested
The purpose of this study is to evaluate the safety and clinical activity o...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2018-02-02
Trial ID
NCT03161379
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This is a prospective, single-center, single-arm, phase II clinical study. ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-01
Trial ID
NCT06573398
Treatments Being Tested
The response rate of HNSCC to immune checkpoint blockade was not satisfied....
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2023-10-01
Trial ID
NCT06306846
Treatments Being Tested
The primary aim is to evaluate the efficacy of neoadjuvant SBRT combined wi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06691594
Treatments Being Tested
The purpose of this study is to evaluate if the combination of nivolumab an...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center
Start Date
2019-12-12
Trial ID
NCT03767582
Treatments Being Tested
This is a Phase II clinical trial evaluating the efficacy and safety of a n...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-12-31
Trial ID
NCT07309952
The primary objective of this study is to evaluate whether neoadjuvant SBRT...
Status
Not Yet Recruiting
Location
Jiangsu Cancer Hospital
Start Date
2025-12-18
Trial ID
NCT07286942
Treatments Being Tested